icon

Scientific Findings: Cancer and Skin Toxicity

December 05, 2020

San Francisco, CA (UCSF Department of DermatologyOriginal Article) April 20th, 2009

Abstract: As inhibitors of the epidermal growth factor receptor (EGFR) become an increasingly common therapeutic option in cancer, appropriate management of their associated toxicities emerges as a critical part of treatment. Cutaneous manifestations, probably linked to the function of the EGFR in epithelial development, are the most common adverse reactions to EGFR inhibition. The key manifestations are follicular eruptions, nail disorders, xerosis, and desquamation. Growing attention continues to be devoted to the analysis of these events, particularly given their potential role as markers of responsiveness to treatment. However, to date, there are few evidence-based guidelines for the appropriate management of these dermatologic events. Multidisciplinary collaboration between oncologists and dermatologists will be required to improve our understanding and optimize the characterization of these skin toxicities, and to design effective management approaches. Read More

published April 20th, 2006

 




Also in News

Guest Post: The Kindness Campaign discusses Skincare during Immunotherapy

January 04, 2022

Read More

Why does Lindi Skin contain fragrances?

December 01, 2021

Fragrance is one of the key decisions to be made when creating any skincare products, and our team of doctors, formulators and skincare experts created our formulas with very explicit instructions to design the products without any unnecessary fragrances, dyes, or ingredients.   

However, the key word here is “unnecessary”. 

Read More

"Be the solution" for a loved-one's skincare issues

November 16, 2021

Lindi Skin CEO Lindy Snider talks about how she created Lindi Skin because her friends could not find skincare to help with their skin issues from cancer treatments... and how you can help your loved ones by introducing them to Lindi Skin.

Read More

Liquid error: Could not find asset snippets/afterpay.liquid